Introduction
Uridine diphosphate-glucose pyrophosphorylase (UGP; also UGPase or UTP:glucose-1-phosphate uridylyl-transferase, EC 2.7.7.9) catalyzes the interconversion of glucose-1-phosphate (Glc-1P) and UTP to UDP-glucose (UDP-Glc) and inorganic pyrophosphate (PP i ), utilizing Mg 2+ as an essential cofactor ( Figure 1 ). This enzyme occupies a central position in the cells of all kingdoms of life because its product UDP-Glc represents an indispensable building block for the synthesis of polysaccharides used for structural or storage purposes (e.g. cellulose in plants ( Kleczkowski et al. 2004 ), β-glucan in yeast (Daran et al. 1995) or glycogen in animals and yeast (Alonso et al. 1995; Daran et al. 1995) ). Moreover, UDP-Glc gives rise to disaccharides like sucrose in plants and trehalose in yeast and slime mold (Daran et al. 1995; Bishop et al. 2002; Kleczkowski et al. 2004) . In eukaryotic cells, UDP-Glc is crucial for the endoplasmic reticulum-associated folding control of glycoproteins (Parodi 2000) and is a precursor of UDP-glucuronic acid used in detoxification processes (Aw and Jones 1984) and of other UDP-activated sugars involved in the synthesis of various glycoconjugates. Finally, organisms possessing exclusively the Leloir pathway (Holden et al. 2003 ) (e.g. mammals and bacteria) need UDP-Glc for the synthesis of UDP-galactose (Figure 1) , requested for the synthesis of lactose (in mammals) and for the entry of galactose into glycolysis (Frey 1996) .
Based on the described vital functions of UGP, defects in the enzyme would most probably not be compatible with the development of living systems and accordingly, pathophysiologies caused by defects in UGP have never been observed in higher vertebrates. Moreover, UGP has been shown to be essential in yeast (Daran et al. 1997) , to be required for fertility in plants (Chen et al. 2007; Woo et al. 2008) and to be an important virulence factor in several bacterial and protozoan pathogens (Sandlin et al. 1995; Chang et al. 1996; Mollerach et al. 1998; Nesper et al. 2001; Priebe et al. 2004; Bonofiglio et al. 2005; Marino et al. 2010; Vilches et al. 2007; Jiang et al. 2010; Klein et al. 2012) , thus providing a promising target for therapeutic interventions.
However, because the crystal structures solved for several prokaryotic (Aragao et al. 2007 ; Thoden and Holden 2007b; Kim et al. 2010 ) and eukaryotic UGPs (Roeben et al. 2006; McCoy et al. 2007; Steiner et al. 2007; Marino et al. 2010; Yu and Zheng 2012) demonstrate a high conservation of the active site architecture even in the absence of significant amino acid sequence conservation, the design of pathogenspecific drugs must focus on allosteric sites. The term allostery in this context is used according to Goodey and Benkovic (2008) , who include in allostery the regulation of enzymes by the binding of effector molecules or proteinprotein interactions at sites distant from the active site.
Regardless of the highly conserved active site architecture, UGPs from various species attain diverse quaternary organizations. Plant UGPs, for instance, are active as monomers and can transiently dimerize to sequestrate the enzyme in an inactive form (Martz et al. 2002; Kleczkowski et al. 2005; McCoy et al. 2007; Meng et al. 2009 ). Likewise, the active species of UGP from the protozoan parasites Leishmania major and Trypanosoma brucei are monomeric (Lamerz et al. 2006; Marino et al. 2010) . In sharp contrast to the plant enzymes, higher assemblies that may represent storage forms were not identified in these parasites, not even after overexpression in the protist cell (Lamerz et al. 2006) . In several bacteria, UGP-dimers (Bosco et al. 2009 ) or tetramers (Chang et al. 1999; Thoden and Holden 2007a, b; Kim et al. 2010) constitute the active species. In Saccharomyces cerevisiae (Roeben et al. 2006 ) and several mammalian species, including humans (Turnquist et al. 1974) , endogenous UGP was found to form an octamer. The crystal structure data obtained for the enzyme from S. cerevisiae identified the β-helix that forms the very C-terminus of the monomeric unit to mediate octamerization (Roeben et al. 2006) . Since residues crucial for the quaternary organization in S. cerevisiae are highly conserved in animal UGPs, a similar mode of oligomerization has been suggested (Roeben et al. 2006 ). Still, it remains an open question whether the octamer represents the functionally active form of the vertebrate enzyme or a means of sequestrating smaller active subunits.
With the aim of gaining insight into the structure-function relationship in vertebrate UGPs, the current study focused on the human UGP (hUGP) and particularly on exploring the interplay between oligomerization and activity. Using the information provided by the S. cerevisiae crystal structure, mutations were introduced into hUGP at conserved positions that were predicted to play a role in octamer formation. The resulting protein variants were simultaneously tested for oligomer formation and functional activity. Here, we provide clear evidence that the octameric state is a prerequisite for activity in the hUGP and thus provide data that will support future attempts to design pathogen-specific UGP inhibitors.
Results
Homo sapiens UGP (hUGP) isoforms 1 and 2 behave identical in terms of oligomer formation and functional activity In humans, as in a multitude of other mammalian species, two isoforms-hUGP1 and hUGP2-are generated from a single gene by alternative splicing (Duggleby et al. 1996) . The only difference between the two proteins is an extension of the very N-terminus of hUGP1 by 11 amino acids. Because the role of this extension for the biological function and quaternary organization of hUGP1 is unknown, we initially included both isoforms in our study. However, since no significant differences were identified in the experimental systems applied, the results presented here are limited to the shorter isoform hUGP2.
hUGP forms enzymatically active octamers Acknowledging the fact that the quaternary organization of hUGP involves the C-terminus (Roeben et al. 2006; Yu and Zheng 2012) , proteins were expressed with an N-terminal StrepII-tag in Escherichia coli BL21(DE3) and purified to homogeneity via StrepII-affinity chromatography (see Figure 3B for StrepII-hUGP2). Size exclusion chromatography (SEC) was then used to determine the oligomerization states. The elution profile obtained for StrepII-hUGP2 in the presence of 300 mM NaCl is displayed in Figure 2A . Under the applied conditions, StrepII-hUGP2 generated a single peak at a retention volume of 11.4 mL, corresponding to an apparent molecular mass of 423.72 kDa and a calculated oligomerization status of 7.2. These values are in good agreement with the described octameric assembly of the protein (Gillett et al. 1971; Turnquist et al. 1974) . The profile of enzymatic activity, measured in vitro in the forward reaction, exactly overlaid the elution profile (Figure 2A ). Homogeneity and integrity of the eluted enzyme were confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- Fig. 1 . Biosynthesis of UDP-Glc and UDP-Gal. All depicted enzymatic reactions are bidirectional. Glc-1P and UTP are converted into UDP-Glc and pyrophosphate by UGP. Generally, three enzymes exist for the production of UDP-Gal. Two of them, GALE and GALT, use UDP-Glc as a substrate and are broadly expressed in all kingdoms of life, constituting the so-called Leloir pathway. The third enzyme, UDP-sugar pyrophosphorylase (USP), exhibits a broader substrate specificity and constitutes the so-called Isselbacher pathway (Isselbacher 1958) , which has so far only been identified in some plant (Kotake et al. 2004; ) and trypanosomatid species (Damerow et al. 2010; Yang and Bar-Peled 2010) . Thus, UDP-Gal production essentially depends on UGP activity in almost all species.
Functional oligomerization of human UGP PAGE) and subsequent Coomassie Blue staining ( Figure 2B ). Of note, congruent SEC and activity profiles were obtained also with lower salt concentrations (0 and 100 mM; data not shown).
With a view to finding out whether enzymatic activity would be accompanied by a change in oligomeric status, SEC experiments were repeated in the presence of either UTP alone or in the presence of both substrates at concentrations identical to those used in the in vitro activity assay (1 mM UTP and 2 mM Glc-1P). The influence of UTP alone was investigated because UGPs from various sources (Kleczkowski 1994; Lamerz et al. 2006; Kim et al. 2010 ) and nucleotidyltransferases in general (Blankenfeldt et al. 2000; Zuccotti et al. 2001 ) have been described to follow a sequential bi-bi reaction mechanism, in which UTP binding is prerequisite for the binding of Glc-1P. Identical elution profiles were obtained in the presence and absence of substrate(s) (data not shown), strongly suggesting that hUGPs are active in the octameric state and do not dissociate during the enzymatic cycle.
A mutational study identified amino acid residues involved in hUGP oligomerization The octameric UGP from S. cerevisiae (Roeben et al. 2006) consists of four dimeric protomers. The subunits are held together by contacts established between amino acid residues that are part of a left-handed β-helix, comprising the last 54 amino acids of the C-terminus (Roeben et al. 2006 ) ( Figure 3A ). This C-terminal β-helix is 78% identical between the UGPs from S. cerevisiae and H. sapiens, and in particular all positions involved in oligomerization are identical or conserved in terms of chemical properties. In order to test whether these positions correspond also in terms of function, seven point mutations (blue arrows pointing upwards in Figure 3A ) were created. Amino acid replacements were guided by the sequence of A. thaliana UGP, which-as other plant UGPs-is known to be active as a monomer (Martz et al. 2002; Kleczkowski et al. 2005; McCoy et al. 2007 ) and incapable of oligomerization via its C-terminus. All mutations caused a change in the chemical quality of the amino acid side chain. The exchange Asn491Pro was expected to cause an additional change in the structure, as it introduces a bend into the final β-strand of A. thaliana UGP (McCoy et al. 2007) , and thus has been speculated to prohibit the formation of the dimeric subunit (Roeben et al. 2006) . Finally, a truncation mutant was constructed by deleting the last eight amino acids (corresponding to β-strand 24), resulting in StrepII-hUGP2-Δ490-497.
While the analysis of the above-described series of mutants was in progress, the crystal structure of hUGP2 was published and confirmed the octameric organization of this enzyme (Yu and Zheng 2012) . In perfect agreement with our starting hypothesis, the crystal structure demonstrated the involvement of the C-terminal left-handed β-helix in the quaternary organization. While the data obtained in our study so far strictly argued for the octamer to be the active enzyme form (see also the following paragraph), Yu and Zheng (2012) described a fully dissociated double mutant Asn491Pro/Leu492Glu with nearly duplicated enzymatic activity. In order to trace this discrepancy, we included the double mutant Asn491Pro/ Leu492Glu in the current study, and for completeness also the single mutant Leu492Glu (indicated by a red arrow in Figure 3A ). All generated mutants were analyzed in parallel as described below.
In-gel assay of hUGP oligomerization status and activity All recombinant StrepII-tagged hUGP variants could be purified to near homogeneity after bacterial expression ( Figure 3B ). In the first step, blue native polyacrylamide gel electrophoresis (BN-PAGE; Wittig et al. 2006 ) was used to comparatively evaluate oligomer formation in wild-type and mutant enzymes. This technology enables the electrophoretic separation of protein complexes under nondenaturing conditions. Wild-type StrepII-hUGP2 migrated exclusively as an octamer, while all mutants suffered dissociation to a certain degree, leading to the appearance of tetramers, dimers and monomers ( Figure 3C , left).
Only low amounts of dissociation products were seen for the mutants His446Ser, Thr448Lys, His497Ala and Leu492Glu. In contrast, introduction of the β-strand bending proline in mutant Asn491Pro, similar to the truncation of the last eight amino acids (Δ490-497), led to complete disappearance of the octamer. However, remarkably, besides the expected predominant appearance of monomers, significant amounts of dimer were visible in both mutants.
Exchange of the three conserved isoleucine residues ( positions 466, 468 and 487 in hUGP2) against the respective amino acids found in A. thaliana caused gradually different effects. In repeated experiments, the mutant Ile466Thr was found to foremost dissociate into di-and monomers, with a (A) Eukaryotic UGPs can be subdivided into three domains as highlighted by the gray scale. The C-terminus, comprising β-strands 17-24 (indicated by horizontal arrows), is highly conserved between S. cerevisiae and H. sapiens (identical positions are shaded in red). Arrows pointing upwards mark positions that were mutated in H. sapiens UGP, introducing the corresponding residues from A. thaliana UGP, in this study. A truncation is marked by the broken vertical line. Numbering refers to H. sapiens UGP2. (B) Purification results for the recombinant StrepII-hUGP2 wild-type and mutant proteins are displayed by silver-stained SDS-PAGE and anti-StrepII-western blot analysis. (C) Left: Separation of wild-type and mutant StrepII-hUGP2 by BN-PAGE. The wild-type enzyme exclusively migrates as an octamer, while all mutants suffer dissociation to different degrees. Recombinant His-tagged L. major UGP (Lm UGP, 56 kDa) indicates the motility of the monomer. Right: In-gel activity testing highlights exclusively octameric forms of hUGP2, as well as monomeric L. major UGP used as positive control. Bovine thyroglobulin (669 kDa), apoferritin (443 kDa) and yeast alcohol dehydrogenase (150 kDa) were used as protein size markers.
Functional oligomerization of human UGP residual amount of octamer. In the mutants Ile468Lys and Ile487Asp, the level of octamer was further decreased and, uniquely in these mutants, bands representing a tetramer appeared in addition to di-and monomers. The mutant Leu492Glu showed little deviation from wild-type and only a minor portion of the protein was dissociated to the monomer. Combining this mutation with Asn491Pro yielded the double mutant Asn491Pro/Leu492Glu which, identical to the mutants Asn491Pro and Δ490-497, was fully dissociated into di-and monomers.
In-gel activity staining ( Figure 3C , right), which detected UGP activity in the forward reaction due to Ca 2+ precipitation of PP i , identified enzymatic activity exclusively in the octamer bands of hUGP variants and thus confirmed the assumption that octamer formation is a prerequisite for hUGP activity. Yet, the lack of activity staining in the case of the rather stable octameric mutant Thr448Lys illustrated that octamer formation is not sufficient for enzymatic activity.
In accord with their complete dissociation in BN-PAGE, the single mutant Asn491Pro, the double mutant Asn491Pro/ Leu492Glu and the truncation mutant Δ490-497 were inactive. L. major UGP, known to be an active monomer, was used as a positive control in this experiment.
Oligomerization and activity of hUGP mutants in solution
With a view to finding out whether the enzyme variants behave identically if tested in solution, we used SEC and in vitro testing of enzymatic activity as additional systems to relate oligomerization status and enzymatic functionality.
SEC was carried out in the presence of 0, 100 and 300 mM NaCl. Independent of the salt concentration, wild-type StrepII-hUGP2 generated a single peak with a retention volume of 11.4 mL (Figure 4 ). Elution profiles precisely overlaying those of wild-type at all salt concentrations were obtained for the mutants His446Ser, Thr448Lys, Ile466Thr, Ile468Lys and His497Ala (data not shown). Although these data nicely mirrored the mobility in BN-PAGE for the mutants His446Ser, Thr448Lys and His497Ala, they were unexpected in the case of the mutants Ile466Lys and Ile468Lys, both showing considerable dissociation in BN-PAGE ( Figure 3C ).
The elution profiles obtained at a salt concentration of 300 mM for mutants deviating from wild-type are shown in Figure 4 . The mutant Ile487Asp eluted at a retention volume of 13.58 mL with a calculated oligomerization state of 2.46, probably representing the tetrameric species seen in BN-PAGE, but was the only mutant that showed a saltdependent dissociation, co-eluting with wild-type in buffers containing 0 or 100 mM NaCl (data not shown). Interestingly, the mutants Asn491Pro and Leu492Glu, showing significantly different migration behavior in BN-PAGE, generated congruent elution profiles in SEC with the major fraction eluting at the position of the octamer and a minor fraction eluting at the position of a dimer (calculated oligomerization status 1.77). The double mutant Asn491Pro/Leu492Glu exclusively eluted at the position of the dimeric species. A peak maximum of 14.76 mL was identified for the truncation mutant Δ490-497, which corresponds to a calculated oligomerization status of 1.46, most likely also representing a dimer. Integrity of all eluted proteins was confirmed by SDS-PAGE and subsequent Coomassie staining (data not shown). Of note, dissociation into monomers as seen in BN-PAGE was not observed in SEC.
In parallel to SEC, StrepII-hUGP2 variants were studied for activity in vitro using the forward and reverse reaction. The relative activity values (with wild-type hUGP defined as 100%) are given in Figure 5 . Though generally complying with the BN-PAGE data, in some cases important differences were seen. The mutants Ile468Lys and Asn491Pro were both dissociated and inactive in BN-PAGE, but in correspondence with their mostly octameric appearance in SEC (see Figure 4 ) retained activities comparable with wild-type in the forward and >50% in the reverse reaction. Moreover, mutant His497Ala, which constituted an active octamer in BN-PAGE and showed wild-type behavior in SEC, was found to exhibit a drastically diminished forward activity, while activity in the reverse reaction remained ca. 70% of wild-type. In agreement with their dissociation in BN-PAGE and SEC, the in vitro activities of double mutant Asn491Pro/Leu492Glu and the truncation mutant Δ490-497 were strongly reduced.
Equilibrium between oligomeric states in active mutants Asn491Pro and Leu492Glu
The parallel appearance of octamers and dimers in the functionally active mutants Asn491Pro and Leu492Glu raised the question whether an equilibrium of interconvertible proteins or discrete protein forms exist. The peaks representing octamer and dimer were therefore isolated and separately incubated in standard buffer in the absence of NaCl and substrates. After 2, 21 and 45 h, aliquots of each oligomeric fraction were re-chromatographed to determine the ratio between octamer and dimer. The data exemplarily shown for the mutant Asn491Pro ( Figure 6A ) clearly demonstrate the re-appearance of the respective other oligomeric species in both octamer and dimer fraction. These data allow to conclude that a dynamic equilibrium exists between octamer and dimer in solution.
In a second experiment, the potential influence of substrates on the oligomerization state of Asn491Pro and Leu492Glu mutants was tested. Here, the proteins were preincubated in standard buffer without NaCl, either in the absence of substrates (apo form of the enzyme) or in the presence of the substrates of the forward (1 mM UTP and 2 mM Glc-1P) or reverse reaction (1 mM UDP-Glc and 2 mM PP i ). The relative octamer/dimer distribution was determined by SEC. As described above for the wild-type, the addition of substrates did not influence the oligomerization pattern of the mutant enzymes. This visualizes that enzymatic activity, even in hUGP mutants with diminished octamer stability, does not lead to dissociation into smaller subunits, and provides additional evidence that the octamer is the active enzyme species.
Discussion
UDP-glucose pyrophosphorylase (UGP) catalyzes the activation of Glc-1P to UDP-Glc, an indispensable metabolite in all cells in all kingdoms of life (Turnquist et al. 1974; Mollerach et al. 1998; Kleczkowski et al. 2004; Roeben et al. 2006) . As a virulence factor of several pathogenic bacteria and protists, UGP has sparked significant interest as a drug target (Sandlin et al. 1995; Chang et al. 1996; Mollerach et al. 1998; Nesper et al. 2001; Priebe et al. 2004; Bonofiglio et al. 2005; Vilches et al. 2007; Jiang et al. 2010; Marino et al. 2010; Klein et al. 2012 ). However, high structural conservation of the active site fold, existing throughout species (including human) even in the absence of sequence similarities, has complicated attempts to develop pathogen-specific UGP inhibitors. A potential way to overcome this obstacle is to delineate the molecular details that distinguish the catalytically active enzymes in different species and, based on this knowledge, initiate the search for inhibitors that selectively block UGPs from pathogens, e.g. by binding to allosteric sites (Goodey and Benkovic 2008) .
An aspect in which UGPs from different species strongly diverge is the relationship between oligomerization state and enzymatic activity (for review see Kleczkowski et al. 2011) . Bacterial UGPs have been demonstrated to be active as diand tetramers (Chang et al. 1999; Thoden and Holden 2007a, b; Bosco et al. 2009; Kim et al. 2010) . In protozoan parasites and plants, monomers constitute the active enzyme. However, while UGP oligomers (foremost dimers) can be formed in plants to sequestrate the enzyme (Sowokinos et al. 1993; Martz et al. 2002; Kleczkowski et al. 2005) , no tendency to form higher quaternary organizations were found in the protozoan UGPs (Lamerz et al. 2006; Steiner et al. 2007; Marino et al. 2010) . In contrast, UGPs of fungi and animals form octamers both in solution and in the crystal package (Roeben et al. 2006; Yu and Zheng 2012 ). Yet, based on the relatively high conservation that exists among all eukaryotic UGPs, Kleczkowski and coworkers Martz et al. (2002) suggested that similar to the situation in plants, oligomers of animal UGPs may provide storage forms that dissociate to release the active monomer. With the current study, we disprove this hypothesis and provide the first unequivocal evidence that hUGPs are functional octamers. Moreover, we demonstrate that mutations which prevent octamer formation destroy hUGP activity and thus contradict a recent report describing the double mutant hUGP Ala491Pro/Leu492Glu as a fully dissociated monomeric enzyme with increased activity (Yu and Zheng 2012) . Taken together, our data describe a property that clearly distinguishes the human enzymes from orthologues in plants, pathogenic bacteria and protozoa.
First challenge for the "monomer-hypothesis" (Martz et al. 2002) derived when UGP from S. cerevisiae-a close homologue to animal UGPs-was demonstrated to be a functional Fig. 5 . For the comparative analysis of in vitro activities, the recombinant StrepII-tagged wild-type and mutant hUGP2 forms were tested in the forward (dark gray bars) and reverse reaction (light gray bars). Activity values were calculated from quadruplicates and are given as relative values, referring to wild-type hUGP as 100%.
Functional oligomerization of human UGP octamer both in solution and in crystal packing (Roeben et al. 2006 ). This yeast UGP structure revealed that the octamer is composed of four longitudinal dimers that assemble side by side to form the octamer. All structural contacts between the subunits were shown to be mediated by aminoacid residues located within the C-terminal β-helix (Roeben et al. 2006) . Importantly, these residues are highly conserved in all animal UGPs, but not in plant and protozoan UGPs, which are known to be active as monomers (Lamerz et al. 2006; McCoy et al. 2007; Marino et al. 2010) . Guided by this structural information, recently also confirmed for hUGP (Yu and Zheng 2012) , we mutated the critical positions in the C-terminal β-helix of hUGP by introducing the corresponding residues from A. thaliana UGP (see Figure 3A) . All mutant enzymes were produced as recombinant proteins with N-terminal StrepII-tags in E. coli in high yields and could be purified to near homogeneity in a single affinity chromatography step. Subsequently, the relationship between octamerization and activity was analyzed by BN-PAGE and SEC, each combined with activity measurements. In all assay systems, wild-type hUGP was a stable octamer that did not show any dissociation under different buffer conditions or salt concentrations, nor in the presence of one or both substrate(s). The latter observation is of special interest because very recently, Decker et al. (2012) confirmed substrate-induced dissociation of plant UGPs and in addition showed that Glc-1P alone was sufficient to cause dissociation. This effect is surprising because all UGPs studied so far have been described to follow an ordered bi-bi reaction mechanism in which binding of UTP in the active site is a prerequisite for Glc-1P binding (Kleczkowski 1994; Lamerz et al. 2006; Kim et al. 2010) . Furthermore, oligomer formation in plant UGPs has been described to occlude the enzyme's active site and thus prevent the entry of substrates (McCoy et al. 2007) . Taken together, the published data indicate that dissociation of plant UGPs may be triggered by substrate binding to allosteric sites, and thus underline the mechanistic differences observed between UGPs from different kingdoms of life.
For the set of hUGP C-terminal mutants generated in this study, gradually different results were obtained in the two assay systems that were applied to investigate oligomerization status and enzymatic activity (summarized in Figure 7) . In BN-PAGE, all mutants suffered dissociation to a certain degree, and hUGP activity was strictly limited to bands representing the octamer. In solution, investigated by SEC, only 5 out of the 10 generated mutants were fully or partially dissociated. Mutants Asn491Pro and Leu492Glu migrated in two peaks, representing octamer and dimer that were shown in further experiments to exist in a dynamic equilibrium ( Figure 6A ). In contrast, only dimers were observed for the mutants Δ490-497 and Asn491Pro/Leu492Glu. Ile487Asp was the only mutant with a salt-dependent oligomerization behavior and co-migrated with wild-type at salt concentrations up to 100 mM NaCl, but dissociated into tetramers at high salt concentrations (300 mM NaCl). These observations, showing that hUGP octamers formed by the mutant proteins are more stable in solution than in BN-PAGE, may be explained by harsher conditions in BN-PAGE, where proteins are loaded with Coomassie Blue to enable size-dependent electrophoretic separation. Since even protein variants that were stably octameric and active in solution did not re-associate into functional complexes after electrophoretic separation, we assume that the presence of Coomassie Blue promotes dissociation and/or prevents re-assembly of hUGP oligomers. In any case, BN-PAGE results confirm that specific aminoacid residues within the C-terminal β-helix are essential for the enzyme's ability to form stable octamers and moreover illustrate the crucial relevance of octamerization to enzymatic activity. To evaluate whether octamer and dimer exist in a dynamic equilibrium in the hUGP2 mutant Asn491Pro, the protein fractions containing octamer and dimer, respectively, were isolated by SEC, separately incubated and re-chromatographed at time points as indicated. A progressive increase in dimer and octamer, respectively, indicates interconversion between the two oligomeric forms. (B) Stability of the octamer in the absence (apo) and presence of the substrates of the forward (UTP + Glc-1P) and reverse (UDP-Glc + PP i ) reaction was tested with the mutants Asn491Pro and Leu492Glu. After parallel incubation for 2 h at room temperature under the indicated conditions, the samples were analyzed by SEC. No sign for activity-induced dissociation was obtained.
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As highlighted in Figure 7 , the data collectively obtained in the different assay systems allow to group the mutants into three categories: (1) Octameric enzymes showing activity in one or both test systems (His446Ser, Ile468Lys, Asn491Pro, Leu492Glu and His497Ala); (2) Dissociated enzymes with no activity in any of the systems (Ile487Asp, Δ490-497 and Asn491Pro/Leu492Glu) and (3) Octameric, but inactive enzymes (Thr448Lys and Ile466Thr). Importantly, mutants Ile466Thr, Ile468Lys and Asn491Pro produced diverging results in the different assay systems: These mutants were entirely or mostly octameric in solution, but dissociated in BN-PAGE, which can be attributed to the comparatively harsher conditions in the latter system.
Together, these results demonstrate that only those hUGP variants retaining the capacity to form octamers are capable of exhibiting enzymatic activity. Moreover, the appearance of octameric but inactive mutants demonstrates that the formation of an octameric complex is not sufficient for hUGP activity. This becomes apparent in the mutant Thr448Lys, which even under the harsher conditions of BN-PAGE migrates foremost as octamer, yet is inactive. Based on the structure of wild-type hUGP2 (Yu and Zheng 2012) , this residue is located almost centrally within the β-sheet that is responsible for the side-by-side contact between neighboring subunits. While replacement of the rather small threonine by the larger lysine residue still allows the formation of a stable octamer, it could sterically hinder the correct folding of the β-sheet and/or distort the subsequent oligomeric assembly in a way that impairs enzymatic function. This illustrates that the integrity of the C-terminal β-helix domain not only serves constructional purposes, but is required for enzymatic functionality of the octamer. Interestingly, mutant His497Ala (which formed stable octamers both in BN-PAGE and SEC) displayed selectively impaired activity in the forward reaction in solution, although activity was detected in BN-PAGE. It is likely that the low residual forward activity also seen in vitro was sufficient to produce a positive signal in BN-PAGE, where extended staining periods were used to visualize active UGPs. To obtain initial information why the in vitro forward reaction was selectively impaired in this mutant, the V max and K m values were determined in comparison with wild-type (see Supplementary data, Figure S1 ). With the substrate UTP, both wild-type and mutant hUGP followed Michaelis-Menten kinetics and exhibited comparable K m values. In contrast, V max was drastically diminished in the mutant ( 4% of wildtype), indicating that His497 has an important role in the enzymatic reaction. As described for UGP from rabbit muscle (Bergamini et al. 1983 ), hUGP did not follow MichaelisMenten kinetics for Glc-1P, thus preventing the determination of K m values for this substrate. In the crystal structure of apo hUGP (Yu and Zheng 2012) , the C-terminal residue His497 is located at the interface between three subunits and extends toward the entrance of the neighboring subunit's active site. Although probably not close enough to make direct contact to the substrates, its positioning as well as the impact on V max of the forward reaction suggest that His497 could be involved in allosteric regulation of hUGP. To finally determine the function of this residue, additional structural studies are needed.
Diverging from our data, the double mutant Asn491Pro/ Leu492Glu was described by Yu and Zheng (2012) to be fully dissociated into monomers and to exhibit increased activity with V max almost doubled compared with wild-type. 
Functional oligomerization of human UGP
None of our experimental systems was capable of confirming this gain in activity. In independent experiments and by use of different assay systems, the simultaneous mutation of the two positions was found to inactivate hUGP. Of note, the single mutant Leu492Glu additionally made in the current study formed active octamers in BN-PAGE and was the only protein variant in which the forward activity in vitro was significantly higher than in wild-type. Additional experiments are needed to explain this particular effect, which for the first time demonstrates a positive impact of manipulations within the C-terminal domain on the enzyme's functionality. As the panels of mutants generated in the current and the former study (Yu and Zheng 2012) overlap only with respect to the double mutant Asn491Pro/Leu492Glu, a direct comparison of data is difficult. Nevertheless, both studies demonstrate that the double mutant is dissociated, a feature that-based on our data-prevents the establishment of a functional enzyme.
Aiming at understanding why octamerization is necessary for hUGP function, an ongoing theoretical analysis of several oligomeric nucleotidyltransferase structures (R. Fedorov, personal communication) has revealed that intermolecular contacts between individual subunits exist in these enzymes which could directly or indirectly participate in stabilization of the substrate's sugar moiety. In the structure of apo hUGP (Yu and Zheng 2012) , it can be observed that residues at the base of the C-terminal β-helix domain (foremost residues R411, F413 and D445) are in close proximity to the sugarbinding loop (and therein foremost residue R276) of the neighboring subunit. Deviating from the earlier interpretation (Yu and Zheng 2012 ) that a "latch loop" (comprising residues 406-416) interferes with hUGP activity, we propose that the mutual interaction between two neighboring subunits in proximity to the active site is in fact necessary for activity. Such a functional interaction, which would request a precise positioning of the subunits, would also explain why even slight disturbances of the octamer assembly can negatively impact on hUGP activity. Of note, while R411 is absolutely conserved throughout eukaryotic UGPs, F413 (C-terminal domain) and R276 (sugar-binding loop) are absolutely conserved only in the octameric UGPs from yeast and animals.
In conclusion, we propose that the correct assembly of individual subunits in the hUGP octamer, which depends essentially on conserved residues in the C-terminal domain, enables a functional interaction between subunits that provides intermolecular stabilization of the sugar-binding site and is essential for full hUGP activity.
Materials and methods
Generation of hUGP expression constructs and site-directed mutagenesis For the generation of expression constructs bearing an N-terminal StrepII-tag, cDNAs encoding for hUGP1 (UniProt: Q16851-1) and hUGP2 (UniProt: Q16851-2) were amplified from the plasmids pFL-hUGP1 and pFL-hUGP2 described by Lamerz et al. (2006) , using the primer pairs ACM10 (CGCGGGATCCTCGAGATTTGTACAAGATC)/ACM9 (ATATGCGGCCGCTCAGTGGTCCAAGATGC) and ACM8 (CGCGGGATCCTCTCAAGATGGTGCTTC)/ACM9 (ATAT GCGGCCGCTCAGTGGTCCAAGATGC), which introduce BamHI and NotI restriction sites (underlined), respectively. Primers were purchased from Sigma-Aldrich (Steinheim, Germany). After BamHI/NotI digestion (New England Biolabs, Frankfurt am Main, Germany) and gel purification (MachereyNagel, Düren, Germany), the PCR products were ligated (T4 DNA ligase, Fermentas/Fisher Scientific, Schwerte, Germany) into a modified, likewise digested pET22b expression vector (Novagen/Merck, Darmstadt, Deutschland) to yield hUGP-constructs containing an N-terminal StrepII-tag followed by a thrombin cleavage site (sequence: MASWSHPQFEKGALV PRGS). The resulting plasmids were termed pET22b-StrepIIhUGP1 and pET22b-StrepII-hUGP2. For the introduction of point mutations and truncations, we applied the QuikChange XL Site-Directed Mutagenesis strategy (Stratagene/Agilent Technologies, Waldbronn, Germany) according to the manufacturer's instructions, or regular PCR amplification using the primers listed in Supplementary data, Table S1 . Integrity of all constructs was confirmed by sequencing (GATC Biotech, Konstanz, Germany).
Recombinant expression of H. sapiens UGPs For recombinant expression, the respective plasmids were transformed into Ca 2+ -competent E. coli BL21(DE3) using heat shock. Bacteria were grown in PowerBroth (AthenaES, Baltimore, MD) at 37°C to an optical density (OD 600 ) of 1.0-1.2 and the expression of recombinant protein was induced by addition of 1 mM IPTG (isopropyl-β-D-thiogalactopyranoside, Applichem, Darmstadt, Germany). After 4 h, the cells were harvested by centrifugation (6000 × g, 15 min, 4°C), washed once with phosphate buffered saline and stored at −20°C until further use.
Purification of recombinant proteins by StrepII-affinity chromatography Each bacterial pellet obtained from 500 mL of Power Broth expression culture was resuspended in 25 mL buffer W (100 mM trishydroxymethylaminomethane (Tris)-HCl pH 8.0, 150 mM NaCl) including protease inhibitors (40 µg/mL bestatin, 0.7 µg/mL pepstatin (both Sigma-Aldrich, Steinheim, Germany), 0.5 µg/mL leupeptine (Serva, Heidelberg, Germany) and 1 mM phenylmethylsulfonyl fluoride (Roche Applied Science, Mannheim, Germany)). Cells were lysed by sonication using a Branson Sonifier (microtip, 50% duty cycle, output control 5) in eight cycles of 30 s, alternating with 30 s of rest. Samples were kept on ice during sonication. Cell debris was removed by centrifugation (20,000 × g, 15 min, 4°C). To remove biotinylated E. coli proteins, the lysate was supplied with 100 µg of avidine (IBA lifesciences, Göttingen, Germany) per 1 L culture of OD = 1, incubated for 30 min at 4°C and cleared by centrifugation (20,000 × g, 15 min, 4°C). The resulting supernatant was passed through a 0.2 µm filter (Millipore/Merck, Darmstadt, Germany) and subsequently loaded onto a 5 mL Strep-Tactin sepharose column (IBA, lifesciences, see above) equilibrated with buffer W. After washing with 10 column volumes of buffer W, the bound StrepII-tagged protein was eluted with buffer E (100 mM Tris-HCl pH 8.0, 150 mM NaCl, 2.5 mM desthiobiotin). Protein-containing fractions were pooled and for storage purposes the buffer was exchanged to 50 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) pH 7.5, 5 mM MgCl 2 , 1 mM ethylenediaminetetraacetic acid (EDTA) and 20% sucrose using PD-10 desalting columns (Amersham Biosciences/GE Healthcare, Freiburg, Germany). Protein samples were flash-frozen in liquid nitrogen and stored at −80°C.
Size exclusion chromatography
To determine the oligomerization status of StrepII-tagged hUGP variants, SEC on a Superdex 200 10/300 GL column (GE healthcare, Freiburg, Germany) was carried out. The column was equilibrated with a buffer composed of 50 mM HEPES pH 7.5, 5 mM MgCl 2 , and NaCl at varying concentrations (0, 100 and 300 mM). A standard curve was created using a protein standard kit from Sigma-Aldrich (see above), applying the same chromatography conditions as employed for StrepII-hUGP. To investigate factors that may affect the oligomerization behavior of the enzymes, one or both substrate(s) of either reaction (1 mM UTP and 2 mM Glc-1P, respectively 1 mM UDP-Glc and 2 mM PP i ) were added to the protein sample prior to chromatography. UTP was purchased from Roche Applied Science, PP i from Sigma-Aldrich, Glc-1P and UDP-Glc from Calbiochem/Merck (Darmstadt, Germany).
SDS-PAGE analysis and immunoblotting SDS-PAGE was performed according to Laemmli with 5% polyacrylamide in the stacking and 10% in the separating gel. Protein bands were visualized with Coomassie Brilliant Blue (RotiBlue, Roth Karlsruhe, Germany) or by silver staining. For western blot analysis, proteins were transferred to nitrocellulose membrane (Schleicher & Schüll/Whatman, Dassel, Germany). StrepII-tagged hUGPs were detected with Strep-Tactin alkaline phosphatase conjugate (IBA lifesciences).
Blue native PAGE and in-gel activity staining BN-PAGE was performed as described for soluble proteins by Wittig et al. (2006) using 6-10% polyacrylamide gradient gels, overlaid with a 3% stacking gel. Coomassie-dyed bands within the gel were documented by scanning on a ODYSSEY imaging system (LI-COR, Bad Homburg, Germany). Subsequently, the activity of different UGP bands was probed by in-gel activity staining according to a protocol modified from Manchenko (2003) . Therefore, the BN-PAGE gels were bathed in a solution (50 mM glycine-KOH pH 9.0, 8 mM MgCl 2 and 5.3 mM CaCl 2 ) supplied with the substrates of the UGP forward reaction (2.3 mM UTP and 1.3 mM Glc-1P). Bands containing an active UGP produced UDP-Glc and PP i , the latter forming a white precipitate with Ca 2+ -ions (Manchenko 2003) . The activity staining was carried out for up to 2 days at room temperature and precipitates were documented on an Alpha Imager UV-light imager (Biozym, Hessisch Oldendorf, Germany).
In vitro activity assays
To quantify enzymatic activity in the forward reaction, the formation of pyrophosphate was continuously detected using the EnzChek pyrophosphate assay kit (Molecular Probes/Life Technologies, Darmstadt, Germany) at fixed substrate concentrations of 1 mM UTP and 2 mM Glc-1P in a buffer composed of 50 mM Tris-HCl pH 7.8 and 10 mM MgCl 2 . For the reverse UGP reaction, the formation of UTP was monitored using a continuous enzymatic assay utilizing CTP synthase as described by Damerow et al. (2010) at fixed substrate concentrations of 1 mM UDP-Glc and 2 mM PP i under the aforementioned buffer conditions. In both cases, the enzymatic reactions were carried out in 96-well half-area flat-bottom microplates (Greiner Bio-One, Frickenhausen, Germany) and initiated by the addition of the StrepII-hUGP variants. Formation of products was continuously monitored at 360 nm using a 96-well microplate reader (Power-WaveTM 340 KC4 system, Bio-Tek, Bad Friedrichshall, Germany). Protein concentrations were calculated from the measured UV-absorbance at 280 nm and the proteins' individual extinction coefficient, which was calculated using ProtParam (http://web.expasy.org/protparam/).
Supplementary data
Supplementary data for this article is available online at http:// glycob.oxfordjournals.org/.
